INFLARX NV's ticker is IFRX and the CUSIP is N44821101. A total of 47 filers reported holding INFLARX NV in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $538,000 | -87.5% | 138,040 | -83.9% | 0.00% | -87.5% |
| Q4 2020 | $4,307,000 | +0.3% | 856,228 | -15.0% | 0.02% | -5.9% |
| Q3 2020 | $4,292,000 | -11.7% | 1,007,559 | -4.8% | 0.02% | -19.0% |
| Q2 2020 | $4,859,000 | -28.5% | 1,058,555 | -40.5% | 0.02% | -50.0% |
| Q1 2020 | $6,794,000 | -3.5% | 1,778,415 | 0.0% | 0.04% | +13.5% |
| Q4 2019 | $7,043,000 | +60.3% | 1,778,415 | 0.0% | 0.04% | +23.3% |
| Q3 2019 | $4,393,000 | -35.1% | 1,778,415 | +893.6% | 0.03% | -30.2% |
| Q1 2019 | $6,764,000 | +3.9% | 178,987 | 0.0% | 0.04% | -18.9% |
| Q4 2018 | $6,510,000 | +6.0% | 178,987 | 0.0% | 0.05% | +32.5% |
| Q3 2018 | $6,143,000 | -26.4% | 178,987 | -30.8% | 0.04% | -36.5% |
| Q2 2018 | $8,347,000 | +44.7% | 258,824 | +29.4% | 0.06% | +28.6% |
| Q1 2018 | $5,768,000 | +37.7% | 200,000 | 0.0% | 0.05% | +36.1% |
| Q4 2017 | $4,190,000 | – | 200,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 1,766,038 | $56,955,000 | 17.85% |
| RA Capital Management | 1,967,148 | $63,441,000 | 4.12% |
| Cormorant Asset Management, LP | 1,487,265 | $47,964,000 | 3.55% |
| Redmile Group, LLC | 2,027,700 | $65,393,000 | 2.22% |
| EMORY UNIVERSITY | 77,554 | $2,501,000 | 1.66% |
| Eventide Asset Management | 275,000 | $8,869,000 | 0.37% |
| Birchview Capital, LP | 16,000 | $516,000 | 0.35% |
| Artal Group S.A. | 500,000 | $16,125,000 | 0.34% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 2,385,659 | $76,938,000 | 0.18% |
| Baker Brothers Advisors | 258,824 | $8,347,000 | 0.06% |